Cited by 193Interstitial Lung Diseases and Idiopathic Pulmonary FibrosisOccupational and environmental lung diseasesChronic Obstructive Pulmonary Disease (COPD) Research

The genetic basis of idiopathic pulmonary fibrosis

Open access
Kropski, Jonathan A., Blackwell, Timothy S., Loyd, James E.·2015·European Respiratory Journal

Abstract

Throughout the past decade, there have been substantial advances in understanding the pathogenesis of idiopathic pulmonary fibrosis (IPF). Recently, several large genome-wide association and linkage studies have identified common genetic variants in more than a dozen loci that appear to contribute to IPF risk. In addition, family-based studies have led to the identification of rare genetic variants in genes related to surfactant function and telomere biology, and mechanistic studies suggest pathophysiological derangements associated with these rare genetic variants are also found in sporadic cases of IPF. Current evidence suggests that rather than existing as distinct syndromes, sporadic and familial cases of IPF (familial interstitial pneumonia) probably reflect a continuum of genetic risk. Rapidly evolving bioinformatic and molecular biology techniques, combined with next-generation sequencing technologies, hold great promise for developing a comprehensive, integrated approach to defining the fundamental molecular mechanisms that underlie IPF pathogenesis.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1183/09031936.00163814

Cites

115 of 115 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • IPF is diagnosed only after other causes of fibrosing interstitial lung disease are excluded, but it has known environmental and genetic risk factors.

    “IPF is considered idiopathic and can only be diagnosed when other causes of fibrosing interstitial lung disease (ILD) have been eliminated; however, it has many known environmental and genetic risk factors [2–4].”

    From Emerging pharmacological options in the treatment of idiopathic pulmonary fibrosis (IPF) (2024) · cites this paper as [3]

    The Introduction states that genetic and environmental factors contribute to IPF risk, and the paper discusses specific genetic variants. Our copy does not state that IPF can be diagnosed only after other causes of fibrosing ILD have been excluded; searches for that diagnostic requirement found no supporting passage. No page number was available for the indexed passages. (LLM, conf=0.85)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

1 retracted

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Kropski, J. A., Blackwell, T. S., & Loyd, J. E.
Affiliations
Vanderbilt University (US)
Venue
European Respiratory Journal
Published
2015-04-02
Volume
45
Issue
6
Pages
1717-1727
ISSN
  • 0903-1936 (ISSN-L)
  • 1399-3003
OpenAlex
W2100190218
Cited by
193
References
115
Citations by year
2026: 6 · 2025: 17 · 2024: 20 · 2023: 24 · 2022: 14 · 2021: 22 · 2020: 19 · 2019: 22 · 2018: 20 · 2017: 8 · 2016: 13 · 2015: 7
FWCI
12.67
Type
journal article
Language
en
Open access
Locations
  • European Respiratory Journal (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
National Institutes of Health (HL085317, HL092870, HL94296)
Topics
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Occupational and environmental lung diseases
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Chronic Obstructive Pulmonary Disease (COPD) Research
Keywords
idiopathic pulmonary fibrosis, genetic susceptibility, genome-wide association study, linkage analysis, rare variants, familial interstitial pneumonia, surfactant function, telomere biology, genetic susceptibility loci
MeSH terms
DNA Helicases, Humans, Lung Diseases, Interstitial, Telomerase, Genetic Predisposition to Disease, Pulmonary Surfactant-Associated Proteins, Intracellular Signaling Peptides and Proteins, Idiopathic Pulmonary Fibrosis, Genome-Wide Association Study, Mucin-5B

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review